Asunto(s)
Neoplasias de la Mama/etiología , Hipobetalipoproteinemias/complicaciones , Apolipoproteína B-100/sangre , Neoplasias de la Mama/genética , Estudios de Casos y Controles , Estudios de Cohortes , Femenino , Heterocigoto , Humanos , Hipobetalipoproteinemia Familiar por Apolipoproteína B/complicaciones , Hipobetalipoproteinemia Familiar por Apolipoproteína B/genética , Hipobetalipoproteinemias/genética , Lipoproteínas LDL/sangre , Factores de RiesgoRESUMEN
BACKGROUND: Low-density lipoprotein cholesterol (LDL-C) levels below 50 mg/dL may suggest familial hypobetalipoproteinemia, particularly in patients with hepatic steatosis. The prevalence of hypobetalipoproteinemia in cohorts with nonalcoholic fatty liver disease (NAFLD) is not known, and it is not clear whether the severity of liver disease of these patients is different. The objective of this study was to address these questions in a large pediatric NAFLD cohort. METHODS: Retrospective study of children followed at the Steatohepatitis Center of a tertiary care center from August 2010 to October 2017. Patients with secondary causes of hepatic steatosis and those on statins were excluded. RESULTS: Of the 740 patients included, 58 (8%) had hypobetalipoproteinemia. These patients were younger (P = .04), had a lower body mass index (P < .01) and waist circumference (P = .01), and were less likely to be on metformin (P = .01). In spite of that, serum aminotransferase levels were not different between those with low, normal, and high LDL-C levels. Of the 222 patients who had both lipid and histology data available, the steatosis score was higher in those with low LDL-C compared to those with normal or elevated LDL-C, a result that trended toward significance (P = .06). The severity of inflammation and fibrosis did not differ between the groups. When all patients with hypertriglyceridemia were excluded, steatosis severity was higher in those with low LDL-C (P = .04). CONCLUSION: Hypobetalipoproteinemia is common among patients with NAFLD and is associated with similar liver disease severity in spite of a leaner phenotype and a more favorable metabolic profile.
Asunto(s)
Hipobetalipoproteinemia Familiar por Apolipoproteína B/sangre , Hipobetalipoproteinemia Familiar por Apolipoproteína B/complicaciones , Lipoproteínas LDL/sangre , Enfermedad del Hígado Graso no Alcohólico/complicaciones , Fenotipo , Adolescente , Niño , Femenino , Humanos , Masculino , Estudios RetrospectivosRESUMEN
No disponible
Asunto(s)
Adulto , Femenino , Humanos , Hiperlipoproteinemia Tipo II/diagnóstico , Hiperlipoproteinemia Tipo II/tratamiento farmacológico , Hipobetalipoproteinemia Familiar por Apolipoproteína B/complicaciones , Hipobetalipoproteinemia Familiar por Apolipoproteína B/diagnóstico , Indicadores de Morbimortalidad , Revascularización Miocárdica/métodos , Revascularización Miocárdica/tendencias , Hipercolesterolemia/complicaciones , Hipolipemiantes/uso terapéuticoRESUMEN
"Primary hypobetalipoproteinemia" refers to an eclectic group of inherited lipoprotein disorders characterized by low concentrations of or absence of low-density lipoprotein cholesterol and apolipoprotein B in plasma. Abetalipoproteinemia and homozygous familial hypobetalipoproteinemia, although caused by mutations in different genes, are clinically indistinguishable. A framework for the clinical follow-up and management of these two disorders has been proposed recently, focusing on monitoring of growth in children and preventing complications by providing specialized dietary advice and fat-soluble vitamin therapeutic regimens. Other recent publications on familial combined hypolipidemia suggest that although a reduction of angiopoietin-like 3 activity may improve insulin sensitivity, complete deficiency also reduces serum cholesterol efflux capacity and increases the risk of early vascular atherosclerotic changes, despite low low-density lipoprotein cholesterol levels. Specialist laboratories offer exon-by-exon sequence analysis for the molecular diagnosis of primary hypobetalipoproteinemia. In the future, massively parallel sequencing of panels of genes involved in dyslipidemia may play a greater role in the diagnosis of these conditions.
Asunto(s)
Abetalipoproteinemia/terapia , Avitaminosis/prevención & control , Dieta con Restricción de Grasas , Hipobetalipoproteinemia Familiar por Apolipoproteína B/terapia , Vitaminas/uso terapéutico , Abetalipoproteinemia/complicaciones , Abetalipoproteinemia/genética , Avitaminosis/etiología , Humanos , Hipobetalipoproteinemia Familiar por Apolipoproteína B/complicaciones , Hipobetalipoproteinemia Familiar por Apolipoproteína B/genética , Hipobetalipoproteinemias/complicaciones , Hipobetalipoproteinemias/genética , Hipobetalipoproteinemias/terapia , Vitamina A/uso terapéutico , Vitamina E/uso terapéuticoRESUMEN
Familial hypobetalipoproteinaemia (FHBL) is a rare monogenic cause of hypocholesterolaemia. Increased liver transaminase concentrations and hepatic steatosis are a common occurrence in FHBL. Although FHBL subjects are protected against atherosclerotic cardiovascular disease, consequences of fatty liver in FHBL over the longer term are not known. We describe a case in which an obese woman with APOB L343V FHBL developed non-alcoholic steatohepatitis-related cirrhosis of the liver. Given the potential for progression to cirrhosis, it would seem prudent to serially monitor the livers of these individuals using biochemical and imaging techniques, particularly in the presence of known risk factors that lead to further liver injury, such as alcohol and caloric excess.
Asunto(s)
Hígado Graso/patología , Hipobetalipoproteinemia Familiar por Apolipoproteína B/patología , Cirrosis Hepática/patología , Hígado/patología , Obesidad/patología , Sustitución de Aminoácidos , Apolipoproteínas B/genética , Hígado Graso/complicaciones , Hígado Graso/genética , Hígado Graso/metabolismo , Femenino , Heterocigoto , Humanos , Hipobetalipoproteinemia Familiar por Apolipoproteína B/complicaciones , Hipobetalipoproteinemia Familiar por Apolipoproteína B/genética , Hipobetalipoproteinemia Familiar por Apolipoproteína B/metabolismo , Hígado/metabolismo , Cirrosis Hepática/etiología , Cirrosis Hepática/genética , Cirrosis Hepática/metabolismo , Persona de Mediana Edad , Obesidad/complicaciones , Obesidad/genética , Obesidad/metabolismoRESUMEN
Una de las características de la Enfermedad de Alzheimer (EA) es su heterogeneidad clínica. Así, la presentación atípica frontal o disejecutiva es cada vez más conocida, aunque los factores subyacentes se desconocen. En este estudio se comparó el rendimiento neuropsicológico de dos grupos de pacientes con EA (variante frontal -EAvf- y típica -EAT-). El grupo EAvf (n = 13) fue seleccionado por la existencia de una hipocaptación frontal. Los resultados revelaron que el grupo EAvf manifestó un tras-torno disejecutivo grave, una sintomatología neuropsiquiátrica más severa (desinhibición y apatía), mayor deterioro funcional y generó mayor sobre-carga en el cuidador que el grupo EAT sin afectación frontal (n = 47). A pesar de que el grupo EAvf rindió más bajo en todos los test neuropsicológicos, solo se encontraron diferencias significativas entre ambos grupos en las tareas de velocidad de procesamiento y visuoconstrucción. El análisis de regresión logística reveló que las puntuaciones de velocidad de procesa-miento y flexibilidad mental predicen significativamente el diagnostico de EAvf. La existencia de reflejo de graspin, anosognosia y la no posesión del APOE e4 también fue más prevalente en el grupo EAvf. Este grupo mostró una predominancia de varones y fue más propenso a tener una historia familiar positiva para la EA. Para concluir, el estudio sugiere que la EAvf representa un subtipo de EA que parece tener características clínicas, neuropsicológicas y genéticas diferentes a la EAT (AU)
Clinical heterogeneity is one of the characteristics of Alzheimer's disease (AD). Hence, the atypical frontal or dysexecutive presentation is becoming increasingly well-known, although the underlying factors are still unknown. In this study, the neuropsychological performance of two groups of patients with AD (frontal variant-ADfv-and typical-TAD) were compared. The ADfv group (n = 13) was selected due to the existence of frontal hypoperfusion on a simple photon emission computer tomography (SPECT). The results revealed that the ADfv group displayed a severe dysexecutive disorder, more severe neuropsychiatric symptomatology (disinhibition and apathy), more functional impairment, and it generated a higher caregiver overload than the TAD group without frontal impairment (n = 47). Despite the facts that the ADfv groups performance was poorer in all the neuropsychological tests, significant group differences were only found in the processing speed and visuoconstruction tasks. Lo-gistic regression analysis revealed that the processing speed and mental flexibility scores significantly predicted a diagnosis of ADfv. The existence of the grasp reflex, anosognosia, and the absence of apolipoprotein E epsilon 4 allele (APOE e4) were also more prevalent in the ADfv group. This group had a predominance of males and it was more likely to have a positive family history of AD. To conclude, the study suggests that ADfv represents a subtype of AD that seems to have different clinical, neuropsychological, and genetic characteristics from TAD (AU)
Asunto(s)
Humanos , Masculino , Femenino , Enfermedad de Alzheimer/psicología , Proteína 1 Relacionada con Receptor de Lipoproteína de Baja Densidad/uso terapéutico , Hipobetalipoproteinemia Familiar por Apolipoproteína B/complicaciones , Hipobetalipoproteinemia Familiar por Apolipoproteína B/psicología , Neuropsicología/métodos , Neuropsicología/organización & administración , Neuropsicología/tendencias , Modelos Logísticos , Apolipoproteína E2/uso terapéutico , Demencia/complicaciones , Demencia/psicologíaRESUMEN
OBJECTIVE: Hepatic steatosis is strongly associated with insulin resistance, but causative mechanisms that link these conditions are still largely unknown. Nowadays, it is difficult to establish whether fatty liver is the cause of insulin resistance or instead the complex metabolic derangements of insulin resistance determine hepatic steatosis and its progression to fibrosis. In patients with familial hypobetalipoproteinemia (FHBL), hepatic steatosis is because of the genetically determined defective form of apolipoprotein B, independently of metabolic derangements. Therefore patients with FHBL represent a good in vivo model to evaluate the relationships between fatty liver and insulin sensitivity. METHODS: We evaluated insulin resistance through HOMA-IR in 60 children with echografic and histological features of steatosis; 30 of whom had nonalcoholic fatty liver disease (NAFLD) and 30 had FHBL. RESULTS: All patients had histological features of hepatic steatosis. Patients with FHBL were hypolipidemic, as expected. No significant differences between two groups were observed in liver function tests. IRI and HOMA-IR were statistically higher in NAFLD subjects compared to the FHBL group. CONCLUSION: In our study, we demonstrated that in children with FHBL, hepatic steatosis is dissociated from insulin resistance. This finding suggests that fat accumulation per se may be not a sufficient causal factor leading to insulin resistance, and that other mediators may be involved in the development of alteration in glucose metabolism and metabolic syndrome in patients with NAFLD.
Asunto(s)
Hígado Graso/metabolismo , Hipobetalipoproteinemia Familiar por Apolipoproteína B/metabolismo , Resistencia a la Insulina , Adolescente , Glucemia/metabolismo , Niño , Ayuno/sangre , Hígado Graso/sangre , Hígado Graso/complicaciones , Femenino , Homeostasis , Humanos , Hipobetalipoproteinemia Familiar por Apolipoproteína B/sangre , Hipobetalipoproteinemia Familiar por Apolipoproteína B/complicaciones , Insulina/sangre , Lípidos/sangre , Pruebas de Función Hepática , Masculino , Síndrome Metabólico/sangre , Síndrome Metabólico/complicaciones , Síndrome Metabólico/metabolismo , Análisis Multivariante , Enfermedad del Hígado Graso no Alcohólico , Factores de RiesgoRESUMEN
Familial hypobetalipoproteinemia (FHBL) is an autosomal codominantly inherited disorder of lipoprotein metabolism characterized by decreased concentrations of low-density lipoprotein-cholesterol and of apolipoprotein B (apoB). Mutations of APOB gene lead to the formation of truncated forms of apoB. The study aimed at determining the truncated form of apoB responsible for FHBL associated with liver cirrhosis in a 27-year-old man. Analysis of the patient's lipoproteins has been performed by SDS-PAGE electrophoresis followed by immunoblotting with monoclonal antibodies. DNA of the family (proband, daughter, wife, father, and mother) was extracted, and PCR amplification was realized; amplicons were screened and sequenced. Electrophoresis allowed us to identify a truncated form of apoB (close to apoB 59%), associated with a new heterozygous apoB variant, 8402 C>G. This mutation creates a stop codon (TAC>TAG, Y2807X) and predicts to generate a truncated protein (apoB-61.9%). No other causes of cirrhosis were established by comprehensive clinical and biological investigations. We described here an unusual clinical observation of a patient with FHBL and early development of liver cirrhosis due to a new truncated form of apoB.
Asunto(s)
Apolipoproteínas B/genética , Hipobetalipoproteinemia Familiar por Apolipoproteína B/complicaciones , Cirrosis Hepática/genética , Adulto , Diagnóstico Precoz , Humanos , Hallazgos Incidentales , Cirrosis Hepática/diagnóstico , MasculinoRESUMEN
BACKGROUND: Familial hypobetalipoproteinaemia (FHBL) is a codominant disorder characterised by fatty liver and reduced plasma levels of low-density lipoprotein (LDL) and its protein constituent apolipoprotein B (apoB). FHBL is linked to the APOB gene in some but not all known cases. In a group of 59 patients with FHBL genotyped for APOB gene mutations, we found three novel splice-site mutations: c.904+4A-->G in intron 8, c.3843-2A-->G in intron 24 and c.4217-1G-->T in intron 25. OBJECTIVE: To assess the effects of these mutations on apoB pre-mRNA splicing. METHODS: ApoB mRNA was analysed in the liver of one proband and in cells expressing APOB minigenes harbouring the mutations found in the other probands. RESULTS: In the liver of the c.3843-2A-->G carrier, an apoB mRNA devoid of exon 25 was identified, predicted to encode a truncated peptide of 1260 amino acids. The analysis of minigene transcripts in COS-1 cells showed that the c.904+4A-->G mutation caused the formation of an mRNA devoid of exon 8, predicted to encode a short apoB of 247 amino acids. The minigene harbouring the c.4217-1G-->T mutation in intron 25 generated an mRNA in which exon 25 joined to a partially deleted exon 26, resulting from the activation of an acceptor site in exon 26; this mRNA is predicted to encode a truncated protein of 1380 amino acids. All these truncated apoBs were not secreted as constituents of plasma lipoproteins. CONCLUSION: These findings demonstrate the pathogenic effect of rare splice-site mutations of the APOB gene found in FHBL.
Asunto(s)
Apolipoproteínas B/genética , Hipobetalipoproteinemia Familiar por Apolipoproteína B/genética , Precursores del ARN/genética , Sitios de Empalme de ARN/genética , Adulto , Animales , Apolipoproteínas B/química , Apolipoproteínas B/deficiencia , Apolipoproteínas B/fisiología , Células COS , Niño , Chlorocebus aethiops , Análisis Mutacional de ADN , Hígado Graso/etiología , Hígado Graso/metabolismo , Femenino , Genes Sintéticos , Genotipo , Humanos , Hipobetalipoproteinemia Familiar por Apolipoproteína B/sangre , Hipobetalipoproteinemia Familiar por Apolipoproteína B/complicaciones , Intrones/genética , Lípidos/sangre , Lipoproteínas/sangre , Hígado/metabolismo , Hígado/patología , Masculino , Empalme del ARN/genética , TransfecciónRESUMEN
Multiple cases with various types of pediatric malabsorption syndromes were evaluated. The clinical manifestations, laboratory findings, pathophysiology, and histopathological descriptions of each patient were analyzed in an effort to clear the pathogenesis of the malabsorption syndromes and the treatments were undertaken. The cases studied, included one patient with cystic fibrosis, two with lactose intolerance with lactosuria (Durand type), one with primary intestinal lymphangiectasia, two with familial hypobetalipoproteinemia, one with Hartnup disease, one with congenital chroride diarrhea, one with acrodermatitis enteropathica, one with intestinal nodular lymphoid hyperplasia (NLH), five with intractable diarrhea of early infancy and four with glycogenosis type Ia. Each case description and outcome is described below: 1. A 15-year-old Japanese boy with cystic fibrosis presented with severe symptoms, including pancreatic insufficiency, bronchiectasis, pneumothorax and hemoptysis. His prognosis was poor. Analysis of the CFTR genes of this patient revealed a homozygous large deletion from intron 16 to 17b. 2. In the sibling case of Durand type lactose intolerance, the subjects'disaccaridase activity of the small bowel, including lactase, were within normal limits. The results of per oral and per intraduodenal lactose tolerance tests confirmed lactosuria in both. These observations suggested, not only an abnormal gastric condition, but also duodenal and intestinal mucosal abnormal permeability of lactose. 3. In the case of primary intestinal lymphangiectasia, the subject had a lymphedematous right arm and hand, a grossly coarsened mucosal pattern of the upper gastrointestinal tract (identified via radiologic examination) and the presence of lymphangiectasia (confirmed via duodenal mucosal biopsy). The major laboratory findings were hypoalbuminemia, decreased immunoglobulin levels and lymphopenia resulting from loss of lymph fluid and protein into the gastro-intestinal tract. 4. In two cases of heterozygous familial hypobetalipoproteinemia, serum total cholesterol and betalipoprotein levels were very low. The subjects presented with symptoms and signs of acanthocytosis and fat malabsorption. Further, one subject had neurological abnormalities such as mental retardation and severe convulsions. Treatment with MCT formula diet corrected the lipid malabsorption. 5. A 5-year-old girl presented with pellagra-like rashes, mental retardation and cerebellar ataxia. An oral tryptophan (Trp) and dipeptide (Trp-Phe) loading test were conducted and the renal clearance of amino acids was also evaluated in this patient and in controls. Following the oral Trp loading test, plasma levels of Trp indicated a lower peak in the case, reaching a maximum at 60 minutes. On the other hand, the oral dipeptide (Trp-Phe) loading test in the Hartnup patient showed the peak Trp plasma level was the same as the control subjects. The renal clearance of neutral amino acids in this case increased to levels 5 to 35 times normal. 6. In the case of congenital chloride diarrhea, the subject had secondary lactose intolerance, dehydration, hyponatremia, hypokalemia, hypochloremia, hyperreninemia and metabolic alkalosis. The chloride content of her fecal fluid was very high. The concentrations were 89-103 mEq/l. In contrast, her urine was chloride-free. The subject's growth and development improved after treatment with lactose free formura and oral replacement of the fecal loses of water, NaCl and KCl. Unfortunately, the patient died of a small bowel intussusception. The kidney histopathological finding was juxtaglomerular hyperplasia by a necropsy. 7. In the case of acrodermatitis enteropathica, the subject had characteristic skin lesions, low serum zinc levels and ALPase activity. An oral ZnSO4 loading test and intestinal mucosal histology by a peroral biopsy were conducted. The serum zinc peak level was 2 hours after the oral ZnSO4 loading test. Infant formula alone could not maintain normal serum zinc ranges. Light microscopic studies of the intestinal villous architecture showed a normal pattern. However, ultrastructual examination of several epithelial cells revealed numerous intracellular vesicles. After zinc therapy, these changes were decreased. The lesions were postulated as the secondary result of zinc deficiency. 8. A 12-year-old girl presented with hypogammaglobulinemia, recurrent infections, chronic diarrhea and intestinal NLH. A barium meal and follow-through examination showed multiple nodules throughout the stomach and intestine. The nodules, all uniform in size, were 2 mm diameter. The barium enema did not show NLH in the colon. Mucosal biopsy of the stomach and jejunum revealed the typical histology of NLH in the lamina propria. Also, achlorhydria was present in this patient and her serum gastrin levels were very high; 315-775 pg/ml. 9. In 4 cases of intractable diarrhea in early infancy (by Avery G B), a jejunal biopsy showed shortening villi and nonspecific enterocolitis. Some patients were found with only low lactase or low lactase and sucrase levels. An electron microscope analysis of the small bowel in 2 cases showed alterations: increased pinocytosis in microvillus membranes and lysosomes by endocytosis of undigested macromolecular substances. I postulated that the stated evidence was causative of this clinical profile. 10. I frequently observed diarrhea as a clinical manifestation in glycogenosis type Ia and lipid malabsorption in one case. The light and electron photomicrographs showed intestinal absorption cells with the glycogen deposits in the inferior devision of nuclei.